文献速递产科母胎医学

妊娠期高血压疾病产后再入院风险及出院降压药处方的差异

Risk of postpartum readmission after hypertensive disorder of pregnancy and variation by discharge antihypertensive medication prescription.
PubMed 文献 · Am J Obstet Gynecol · 2024-01-25

这项回顾性队列研究纳入2012至2018年Kaiser Permanente北加州电子产科数据库中57,254例妊娠期高血压疾病孕妇,评估出院时降压药类型与产后6周内再入院的关系。调整混杂因素后,仅拉贝洛尔处方与再入院风险升高相关(HR 1.63),仅硝苯地平或≥2种降压药与再入院风险降低相关(HR 0.74和0.53)。作者认为需大规模前瞻性研究比较常用出院降压药的效果。

要点

  • 出院仅拉贝洛尔处方者产后再入院风险较无处方者升高(HR 1.63,95%CI 1.41-1.88)。
  • 出院仅硝苯地平或≥2种降压药者再入院风险较无处方者降低(HR 0.74和0.53)。
  • 出院降压药类型与再入院风险的关联未显示受种族和族裔影响(交互P=.88)。

核心结论

  • 出院仅硝苯地平处方或多种降压药处方(对比无药物处方)与再入院发生率降低相关,而仅拉贝洛尔处方与再入院发生率升高相关。
  • 作者认为有必要开展大规模前瞻性研究比较常用出院降压药的有效性。

研究设计与样本

  • 回顾性队列研究,纳入2012至2018年Kaiser Permanente北加州电子产科数据库中57,254例妊娠期高血压疾病孕妇。
  • 产后再入院定义为分娩住院出院后6周内发生的再入院。
  • 采用Cox回归模型评估出院降压药处方类型(无、仅拉贝洛尔、仅硝苯地平、≥2种降压药)与产后再入院的关联,并调整妊娠期高血压疾病类型、出院前收缩压和舒张压、年龄、体重指数、分娩方式、保险状态、种族和族裔、分娩机构、合并症评分、吸烟、早产、产次和邻里剥夺指数。

主要发现

  • 1696例(3.0%)在6周内再入院。
  • 约86%患者出院时无降压药处方;有处方者中多数为仅拉贝洛尔(54%)或仅硝苯地平(30%)。
  • 未调整再入院风险:仅拉贝洛尔组最高(7.6%),仅硝苯地平组(3.6%)和≥2种降压药组(3.2%)较低,无降压药处方组最低(2.5%)。
  • 调整模型中,对比无降压药处方,仅拉贝洛尔处方的产后再入院发生率升高63%(HR 1.63,95%CI 1.41-1.88),仅硝苯地平处方和≥2种降压药处方的产后再入院发生率分别降低26%(HR 0.74,95%CI 0.59-0.93)和47%(HR 0.53,95%CI 0.38-0.74)。
  • 无强证据表明出院降压药类型对再入院发生率的影响因种族和族裔而异(交互P=.88);排除孕前高血压患者的模型中,拉贝洛尔相关风险升高的结果一致。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with hypertensive disorders of pregnancy have a high rate of postpartum readmission. OBJECTIVE: This study aimed to evaluate whether the type of antihypertensive medication prescribed at discharge was associated with postpartum readmission after a hypertensive disorder of pregnancy. STUDY DESIGN: This was a retrospective cohort study of 57,254 pregnancies complicated by hypertensive disorders of pregnancy between 2012 and 2018 in the electronic obstetrical database of Kaiser Permanente Northern California. Postpartum readmissions occurred within 6 weeks after discharge from delivery hospitalization. Cox regression models were used to evaluate the association between the type of antihypertensive medication prescription at discharge (none, labetalol only, nifedipine only, or 2 or more antihypertensive medications) and postpartum readmission, adjusted for type of hypertensive disorder of pregnancy, final inpatient systolic and diastolic blood pressures, age, body mass index, mode of delivery, insurance status, race and ethnicity, delivery facility, comorbidity score, smoking, preterm delivery, parity, and Neighborhood Deprivation Index. RESULTS: Among eligible patients with a hypertensive disorder of pregnancy, 1696 (3.0%) were readmitted within 6 weeks. Approximately 86% of patients were discharged without a prescription for antihypertensive medication; among those discharged with a prescription for antihypertensive medication, most were prescribed either labetalol only (54%) or nifedipine only (30%). The unadjusted readmission risk was the highest for patients discharged with a prescription for labetalol only (7.6%), lower for those discharged with a prescription for nifedipine only (3.6%) or 2 or more antihypertensive medications (3.2%), and the lowest for those discharged without a prescription for antihypertensive medication (2.5%). In the adjusted models, compared with discharge without a prescription for antihypertensive medication, discharge with a prescription for labetalol only was associated with a 63% (hazard ratio, 1.63; 95% confidence interval, 1.41-1.88) greater incidence of postpartum readmission, and discharge with a prescription for nifedipine only and discharge with a prescription for 2 or more antihypertensive medications were associated with 26% (hazard ratio, 0.74; 95% confidence interval, 0.59-0.93) and 47% (hazard ratio, 0.53; 95% confidence interval, 0.38-0.74) lower incidence of postpartum readmission, respectively. There was no strong evidence to suggest that the effect of the type of antihypertensive medication at discharge on the incidence of readmission varied by race and ethnicity (interaction P=.88). The results indicating an elevated risk associated with labetalol use were consistent in models that excluded patients with prepregnancy hypertension. CONCLUSION: Discharge with a prescription for nifedipine alone or multiple antihypertensive medications (vs no medication) was associated with a lower incidence of readmission, whereas discharge with a prescription for labetalol alone was associated with an elevated readmission incidence. A large-scale, prospective research to compare the effectiveness of commonly prescribed hypertension medications at discharge is warranted.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Mitro SD, Hedderson M, Xu F, et al. Risk of postpartum readmission after hypertensive disorder of pregnancy and variation by discharge antihypertensive medication prescription. Am J Obstet Gynecol. 2024. PMID: 38280432. doi:10.1016/j.ajog.2024.01.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。